DE60329237D1 - Kristalline form von linezolid - Google Patents

Kristalline form von linezolid

Info

Publication number
DE60329237D1
DE60329237D1 DE60329237T DE60329237T DE60329237D1 DE 60329237 D1 DE60329237 D1 DE 60329237D1 DE 60329237 T DE60329237 T DE 60329237T DE 60329237 T DE60329237 T DE 60329237T DE 60329237 D1 DE60329237 D1 DE 60329237D1
Authority
DE
Germany
Prior art keywords
linezolid
crystalline form
preparation
relates
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60329237T
Other languages
English (en)
Inventor
Rao Dodda Mohan
Reddy Pingili Krishna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Symed Labs Ltd
Original Assignee
Symed Labs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34430675&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60329237(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Symed Labs Ltd filed Critical Symed Labs Ltd
Application granted granted Critical
Publication of DE60329237D1 publication Critical patent/DE60329237D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60329237T 2003-10-16 2003-10-16 Kristalline form von linezolid Expired - Lifetime DE60329237D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000336 WO2005035530A1 (en) 2003-10-16 2003-10-16 A novel crystalline form of linezolid

Publications (1)

Publication Number Publication Date
DE60329237D1 true DE60329237D1 (de) 2009-10-22

Family

ID=34430675

Family Applications (2)

Application Number Title Priority Date Filing Date
DE2009163348 Pending DE09163348T1 (de) 2003-10-16 2003-10-16 Kristalline Form von Linezolid
DE60329237T Expired - Lifetime DE60329237D1 (de) 2003-10-16 2003-10-16 Kristalline form von linezolid

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE2009163348 Pending DE09163348T1 (de) 2003-10-16 2003-10-16 Kristalline Form von Linezolid

Country Status (10)

Country Link
US (4) US7714128B2 (de)
EP (3) EP2902386B1 (de)
AT (1) ATE442364T1 (de)
AU (1) AU2003278592A1 (de)
DE (2) DE09163348T1 (de)
DK (1) DK1673370T3 (de)
ES (3) ES2803516T3 (de)
HU (1) HUE051230T2 (de)
PT (1) PT1673370E (de)
WO (1) WO2005035530A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2803516T3 (es) 2003-10-16 2021-01-27 Symed Labs Ltd Una forma cristalina de linezolid
WO2005099353A2 (en) 2004-04-19 2005-10-27 Symed Labs Limited A novel process for the preparation of linezolid and related compounds
US20060142283A1 (en) * 2004-06-29 2006-06-29 Judith Aronhime Crystalline form IV of linezolid
US20060111350A1 (en) * 2004-06-29 2006-05-25 Judith Aronhime Solid forms of linezolid and processes for preparation thereof
WO2006091731A2 (en) * 2005-02-24 2006-08-31 Teva Pharmaceutical Industries Ltd. Processes for the preparation of linezolid intermediate
DK1749517T3 (da) * 2005-07-20 2008-11-03 Teva Pharma Stabil farmaceutiske sammensætning af linezolid form IV
EP2033960A3 (de) 2007-09-04 2009-04-29 Dipharma Francis S.r.l. Kristalline Linezolidhydratform und Linezolidsalze
IT1390957B1 (it) * 2008-07-07 2011-10-27 Dipharma Francis Srl Sali di linezolid e loro uso nella preparazione di forme cristalline di linezolid
US20090093631A1 (en) * 2007-09-06 2009-04-09 Ben-Zion Dolitzky Processes for the preparation of a linezolid intermediate, linezolid hydroxide
WO2009140466A2 (en) * 2008-05-14 2009-11-19 Dr. Reddy's Laboratories Ltd. Linezolid co-crystals
EP2493867A1 (de) 2009-10-28 2012-09-05 Synthon BV Verfahren zur herstellung einer kristallinen form von linezolid
WO2011050826A1 (en) * 2009-10-28 2011-05-05 Synthon B.V. Process for making crystalline form a of linezolid
EP2516408A1 (de) 2009-12-26 2012-10-31 Alembic Pharmaceuticals Limited Verfahren zur herstellung von linezolid
CN103140487A (zh) 2010-08-11 2013-06-05 斯索恩有限公司 制备利奈唑胺的方法
EP2690100A1 (de) 2010-08-11 2014-01-29 Synhton B.V. Verfahren zur Linezpolid Herstellung
WO2012029074A2 (en) 2010-09-02 2012-03-08 Hetero Research Foundation Pharmaceutical compositions of linezolid
CN102070548B (zh) * 2011-01-13 2012-12-26 浙江新东港药业股份有限公司 一种晶型ⅰ型利奈唑胺的蒸发结晶工艺
WO2012114354A1 (en) 2011-02-24 2012-08-30 Lee Pharma Limited Anhydrous linezolid crystalline form-ii
WO2012119653A1 (en) 2011-03-09 2012-09-13 Synthon Bv Process for making crystalline form a of linezolid
CN102766106A (zh) * 2011-05-03 2012-11-07 江苏豪森医药集团有限公司 利奈唑胺的新晶型及其制备方法
ITMI20111311A1 (it) * 2011-07-14 2013-01-15 Dipharma Francis Srl Sali di linezolid e loro uso nella preparazione di forme cristalline di linezolid
WO2013072923A1 (en) 2011-09-19 2013-05-23 Cadila Healthcare Limited Process for the preparation of crystalline linezolid
WO2013093751A1 (en) * 2011-12-24 2013-06-27 Alembic Pharmaceuticals Limited Packaging for linezolid
EP2852580A1 (de) 2012-01-24 2015-04-01 Jubilant Life Sciences Ltd. Verbessertes verfahren zur herstellung von stabiler kristalliner form-i von linezolid, im wesentlichen frei von lösungsmittelresten
WO2013120496A1 (en) 2012-02-14 2013-08-22 Pharmathen S.A. Process for the preparation of linezolid in crystalline form and salts thereof
WO2013190559A1 (en) * 2012-06-19 2013-12-27 Symed Labs Limited Improved processes for the preparation of linezolid crystalline form iii
US9492459B2 (en) * 2012-08-10 2016-11-15 Indoco Remedies Limited Pharmaceutical composition of linezolid
WO2014071990A1 (en) 2012-11-09 2014-05-15 Synthon Bv Process for making linezolid
WO2014118809A1 (en) 2013-01-29 2014-08-07 Actavis Group Ptc Ehf. Pharmaceutical composition with linezolid
IN2013MU03508A (de) 2013-11-06 2015-07-24 Unimark Remedies Ltd
CN105254580B (zh) * 2014-04-22 2018-01-02 江苏豪森药业集团有限公司 利奈唑胺晶型的制备方法
IN2015CH00214A (de) * 2015-01-13 2015-04-24 Nosch Labs Private Ltd
WO2018051360A1 (en) * 2016-09-16 2018-03-22 Lee Pharma Limited A novel process for the preparation of crystalline linezolid form-iii
SG11202003537TA (en) 2017-11-16 2020-05-28 Persica Pharmaceuticals Ltd Linezolid formulations
CN110194750A (zh) * 2019-06-19 2019-09-03 四川美大康华康药业有限公司 一种利奈唑胺的制备方法及精制方法
WO2023062080A1 (en) 2021-10-12 2023-04-20 Persica Pharmaceuticals Ltd. Low back pain treatment

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US583870A (en) * 1897-06-01 Wrench
DE2810349A1 (de) 1978-03-10 1979-09-20 Kali Chemie Pharma Gmbh Verfahren zur herstellung von 3-hydroxy-6-phenyl-1,2,3,4-tetrahydro- 1,5-benzodiazocinen
FR2506769A2 (fr) 1978-06-09 1982-12-03 Delalande Sa Para-((cyano-5 n pentyl-1) phenyl)-3 methoxymethyl-5 oxazolidinone-2, son procede de preparation et ses applications en therapeutique
US4340606A (en) 1980-10-23 1982-07-20 E. I. Du Pont De Nemours And Company 3-(p-Alkylsulfonylphenyl)oxazolidinone derivatives as antibacterial agents
FR2608604B1 (fr) 1986-12-19 1989-04-28 Delalande Sa Derives 5-hydroxyethyles de l'oxazolidinone-2, leurs procedes de preparation et leurs applications en therapeutique
US5006528A (en) 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
DE9310451U1 (de) 1993-03-05 1994-06-30 Landis & Gyr Business Support Ag, Zug Steuer- bzw. Regeleinrichtung für Gas-Feuerungsautomaten von Heizungsanlagen
EP0615095B1 (de) 1993-03-11 1997-05-07 Landis & Gyr Technology Innovation AG Brennerregler
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5688792A (en) 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
SK284703B6 (sk) 1996-04-11 2005-09-08 Pharmacia & Upjohn Company Spôsob prípravy substituovaných oxazolidinón alkoholov
EP0890791A1 (de) 1997-07-11 1999-01-13 Electrowatt Technology Innovation AG Steuer- und Regelgerät für einen Brenner
KR100580408B1 (ko) 1997-11-07 2006-05-16 파마시아 앤드 업존 캄파니 엘엘씨 옥사졸리디논의 제조 방법
US6444813B2 (en) * 2000-02-02 2002-09-03 Pharmacia & Upjohn Company Linezolid-crystal form II
AR027261A1 (es) 2000-02-02 2003-03-19 Upjohn Co Linezolid forma cristalina ii
MY127336A (en) 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
DE10037585A1 (de) * 2000-08-02 2002-02-14 Valeo Schalter & Sensoren Gmbh Rückstellvorrichtung für einen Blinkerschalter in Kraftfahrzeugen
WO2002014286A1 (en) * 2000-08-14 2002-02-21 Teva Pharmaceutical Industries Ltd. Preparation of risperidone
JP2004520432A (ja) * 2001-02-05 2004-07-08 ファルマシア・アンド・アップジョン・カンパニー オキサゾリジノン抗菌薬の直腸送達のための組成物
JP2005504007A (ja) 2001-04-20 2005-02-10 ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー オキサゾリジノンの製法
CN1155585C (zh) 2001-12-19 2004-06-30 中国医学科学院医药生物技术研究所 3,5－取代噁唑烷酮衍生物及其制备方法和应用
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
ES2803516T3 (es) 2003-10-16 2021-01-27 Symed Labs Ltd Una forma cristalina de linezolid
WO2005099353A2 (en) 2004-04-19 2005-10-27 Symed Labs Limited A novel process for the preparation of linezolid and related compounds
US20060142283A1 (en) * 2004-06-29 2006-06-29 Judith Aronhime Crystalline form IV of linezolid
US7429661B2 (en) 2004-07-20 2008-09-30 Symed Labs Limited Intermediates for linezolid and related compounds

Also Published As

Publication number Publication date
ES2331001T3 (es) 2009-12-18
EP2100884A1 (de) 2009-09-16
WO2005035530A1 (en) 2005-04-21
ATE442364T1 (de) 2009-09-15
US7714128B2 (en) 2010-05-11
ES2803516T3 (es) 2021-01-27
DE09163348T1 (de) 2010-01-07
US7718799B2 (en) 2010-05-18
US20080091011A1 (en) 2008-04-17
US7718800B2 (en) 2010-05-18
EP2902386A1 (de) 2015-08-05
EP1673370B1 (de) 2009-09-09
EP1673370A1 (de) 2006-06-28
PT1673370E (pt) 2009-11-05
US7732597B2 (en) 2010-06-08
HUE051230T2 (hu) 2021-03-01
DK1673370T3 (da) 2009-12-07
EP2902386B1 (de) 2020-04-08
AU2003278592A1 (en) 2005-04-27
US20080090820A1 (en) 2008-04-17
US20080090824A1 (en) 2008-04-17
ES2331454T1 (es) 2010-01-05
US20060128703A1 (en) 2006-06-15

Similar Documents

Publication Publication Date Title
DE60329237D1 (de) Kristalline form von linezolid
DE60315368D1 (de) Korrektur des Weissabgleichs
NO20062644L (no) DPP-IV inhibitorer
CO5611137A2 (es) Composiciones de clorhidrato de naltrexona
CY2013036I2 (el) Συνθεσεις εμβολιου κατα της ναϊσσερια, που περιεχουν εναν συνδυασμο αντιγονων
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
DE60238917D1 (de) Modifikation des ölprofils von pflanzen
DE60333020D1 (de) Anzeigeeinrichtung des dünnen typs
ATE428701T1 (de) Kristalline form von bisä(e)-7-ä4-(4-fluorphenyl)-6-isopropyl-2-
IL159418A0 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
IL166483A0 (en) Pharmaceutical compositions containing ciclesonideand an antihistamine
DE60111497D1 (de) Linezolid-krystall form ii
UY27250A1 (es) Fenil-heterociclil-cteres
DE50213650D1 (de) Einrichtung zur Herstellung von Stapelpaketen
BR0206044B1 (pt) Composição alvejante
DK1644385T3 (da) Siliciumforbindelser og deres anvendelse
DE60201084D1 (de) Herstellung von cyclischen esteroligomeren
DE602004030779D1 (de) Angehen des problems des schrittmachersyndroms
ATE474824T1 (de) Herstellung von olefinen
DE60307022D1 (de) Herstellung von Organohalosilanen
DK1648906T3 (da) Organo-silicium-forbindelser og deres anvendelse
ATE328595T1 (de) Carvedilolpolymorph
SE0200117D0 (sv) Novel compounds
SE0201857D0 (sv) Novel compounds
TH58437EX (th) ตัวเรือนนาฬิกา

Legal Events

Date Code Title Description
8363 Opposition against the patent
R082 Change of representative

Ref document number: 1673370

Country of ref document: EP

Representative=s name: LEDERER & KELLER, 80538 MUENCHEN, DE